Healthcare
United Therapeutics Corporation
UTHRPrice is delayed.
About United Therapeutics Corporation
United Therapeutics makes drugs to treat serious lung diseases, particularly pulmonary arterial hypertension, which is a condition where blood pressure in the lungs becomes dangerously high. Their main products are Tyvaso and Remodulin, which are inhaled or injected medicines that help patients breathe easier and exercise better. The company also sells Unituxin, a cancer treatment for a type of childhood tumor called neuroblastoma. Beyond their current medicines, United Therapeutics is developing experimental treatments including xenotransplantation, which is the transplantation of organs grow…
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore